Featured Lectures

Thursday, March 26
1:30-2 pm

James Ewing Lecture
Peter WT Pisters, MD, MHCM
President
The University of Texas MD Anderson Cancer Center
Houston, TX

Thursday, March 26
2-2:30 pm

John Wayne Clinical Research Lecture
“Building Collaborations to Create a Learning Health System”
Monica M. Bertagnolli, MD
Chief, Division of Surgical Oncology, Brigham and Women’s Hospital
Richard E. Wilson Professor of Surgery, Division of Surgical Oncology, Harvard Medical School
Dana-Farber Cancer Institute
Boston, MA

Friday, March 27
9-9:30 am

SSO Presidential Address
David L. Bartlett, MD
Bernard Fisher Professor of Surgery
Vice Chair, Gastrointestinal and Surgical Oncology Services Director, Koch Center for Regional Therapy
University of Pittsburgh UPMC Health System
Pittsburgh, PA 

 

Featured Lecturers' Bios

  

22  

Peter WT Pisters, MD, MHCM
President
The University of Texas MD Anderson Cancer Center
Houston, TX

Dr. Pisters is president of The University of Texas MD Anderson Cancer Center, where he previously served in faculty and leadership positions for more than 20 years. His appointment to the presidential post, effective December 1, 2017, followed an international search and a unanimous naming as sole finalist by The University of Texas System Board of Regents.

Renowned as a cancer surgeon, researcher, professor and hospital administrator, Dr. Pisters earned his medical degree at The Schulich School of Medicine and Dentistry at Western University in Ontario, Canada. He completed his master’s degree in health care administration at Harvard University School of Public Health and did his postgraduate work at Memorial Sloan Kettering Cancer Center in New York, where he was chief administrative fellow. He earned designation as a Certified Physician Executive in 2014 and was named a fellow of both the American College of Healthcare Executives and the American College of Surgeons.

Most recently, Dr. Pisters led more than 14,000 employees and 1,700 physicians as president and chief executive officer of the University Health Network (UHN) in Toronto, Canada. UHN is Canada’s largest academic medical center. Affiliated with the University of Toronto, which recently ranked as the 12th most outstanding academic institution in the world, UHN has a $400 million research enterprise. It advances studies in cardiology, transplantation, neurosciences, oncology, surgical innovation, infectious diseases, genomic medicine and rehabilitation medicine. In Toronto, Dr. Pisters also served as president and chief executive officer of The Michener Institute of Education and as a professor of Surgery at the University of Toronto.

Originally arriving at MD Anderson in 1994 from a surgery instructor position at Memorial Sloan Kettering, he joined the faculty as assistant professor of Surgery. He rose to full professor with tenure in 2004 and was repeatedly honored during his two decades at MD Anderson, earning two Fellows Outstanding Teacher awards and three Faculty Excellence awards. Dr. Pisters became medical director and eventually vice president for MD Anderson’s regional care system, comprising multiple Houston-area locations. He previously served as clinical consultant for the Center for Global Oncology (now MD Anderson Cancer Network®), section chief for Sarcoma Surgery and assistant medical director of the Sarcoma Center. He specialized in helping patients with sarcomas and gastrointestinal (GI) cancers and remains a board-certified surgeon.

Dr. Pisters is a member of more than two dozen national organizations and currently serves or has served in leadership positions on the advisory boards of numerous others, including several for the National Cancer Institute. He is on the editorial board of the Journal of Clinical Oncology and Surgery and serves as a reviewer for multiple others. His own research, focused on sarcomas, GI cancers and other malignancies, has resulted in nearly 400 peer-reviewed and additional articles, book chapters, teaching aids and other publications.  

 
  sss Monica M. Bertagnolli, MD
Chief, Division of Surgical Oncology, Brigham and Women’s Hospital
Richard E. Wilson Professor of Surgery, Division of Surgical Oncology, Harvard Medical School
Dana-Farber Cancer Institute
Boston, MA


Dr. Monica Bertagnolli is the Richard Richard E. Wilson Professor of Surgery in the Field of Surgical Oncology at Harvard Medical School and an Associate Surgeon at Dana Farber/Brigham and Women’s Cancer Center (DF/BWCC).  She previously served as the Chief of the Division of Surgical Oncology from 2007-2018.  She is a member of the Gastrointestinal Cancer and Sarcoma Disease Centers at DF/BWCC, where she collaborates with colleagues in medical oncology, radiation oncology, and pathology to treat cancer patients in a tertiary care setting. Additionally, Dr. Bertagnolli was elected as the President of the American Society of Clinical Oncology and is currently serving her term until June 2019.

Dr. Bertagnolli graduated from Princeton University and attended medical school at the University of Utah.  She trained in surgery at Brigham and Women’s Hospital and was a research fellow at the Dana Farber Cancer Institute.  Dr. Bertagnolli’s laboratory work focuses on understanding the role of the inflammatory response in epithelial tumor formation.  From 1994-2011, she led gastrointestinal correlative science initiatives within the NCI-funded Cancer Cooperative Groups, where she facilitated integration of tumor-specific molecular markers of treatment outcome into nation-wide clinical cancer treatment protocols.  Dr. Bertagnolli has held numerous leadership roles in multi-institutional cancer clinical research consortia and currently serves as the Group Chair of the Alliance for Clinical Trials in Oncology, a new NCI-funded clinical trials group formed in 2011 by the merger of Cancer and Leukemia Group B, the North Central Cancer Treatment Group, and the American College of Surgeons Oncology Group.  She is also the Chief Executive Officer of Alliance Foundation Trials, LLC, a not-for-profit corporation that conducts international cancer clinical trials. 

  

  

22  

David L. Bartlett, MD
Bernard Fisher Endowed Professor of Surgery
Chief of Surgery
Vice Chair, Surgical Oncology and GI Surgical Services
University of Pittsburgh
Pittsburgh, PA 

David Bartlett is the Bernard Fisher Endowed Professor of Surgery, Chief of Surgery for UPMC Shadyside Hospital, Vice Chairman for Surgical Oncology and GI Surgical Services for the University of Pittsburgh, Director of Multidisciplinary Disease Site Programs at UPCI, and the President of the Society of Surgical Oncology.  Dr. Bartlett is a specialist in the regional delivery of chemotherapy to different organ systems.  His clinical expertise lies in the management of advanced, complex abdominal cancers such as those of the liver, gallbladder and pancreas.  He has a very active clinical practice and productive laboratory.  His laboratory specializes is in the development of oncolytic viruses for regional therapy. He developed tumor selective oncolytic vaccinia viruses that have been tested in pre-clinical models and clinical trials.